Rastogi N, Frehel C
Service de la Tuberculose et des Mycobactéries, Institut Pasteur, Paris, France.
Zentralbl Bakteriol. 1990 Mar;272(3):337-46. doi: 10.1016/s0934-8840(11)80036-8.
Mycobacterium leprae extracted and purified from experimentally infected armadillo was coated with rabbit sera raised against the total antigens of the following species of mycobacteria: M. leprae, M. avium, M. bovis BCG, and M. fallax. In addition, the bacteria were also coated either with serum from a lepromatous (LL), or a tuberculoid (TT) leprosy patient. The effectiveness of surface coating was verified by electron microscopy, with the aid of gold immunolabelling. The coated bacilli were phagocytized by mice bone marrow-derived macrophages, and the phagosome-lysosome fusions (PLF) were assessed during phagocytosis using acid-phosphatase (AcPase) cytochemistry. As compared to control preparations (like-wise treated with non-immune serum), significant but partial reversion of PLF inhibition was observed in all cases except when bacteria had been incubated with M. fallax antiserum (rapidly growing, non-pathogenic species). The results obtained suggest that some of the antimycobacterial antibodies may offer partial protection to the host during early events of infection by reverting the usual pattern of inhibition of PLF in infected macrophages.
从实验感染的犰狳中提取并纯化的麻风分枝杆菌,用针对以下分枝杆菌属总抗原产生的兔血清包被:麻风分枝杆菌、鸟分枝杆菌、卡介苗、衰落分枝杆菌。此外,细菌还用瘤型(LL)或结核样型(TT)麻风患者的血清包被。借助金免疫标记,通过电子显微镜验证表面包被的有效性。包被的杆菌被小鼠骨髓来源的巨噬细胞吞噬,并在吞噬过程中使用酸性磷酸酶(AcPase)细胞化学评估吞噬体 - 溶酶体融合(PLF)。与对照制剂(同样用非免疫血清处理)相比,除了细菌与衰落分枝杆菌抗血清(快速生长的非致病性菌种)孵育的情况外,在所有情况下均观察到PLF抑制的显著但部分逆转。所得结果表明,一些抗分枝杆菌抗体可能通过逆转感染巨噬细胞中PLF的通常抑制模式,在感染早期为宿主提供部分保护。